ONCO110-0918: Cancer and the Immune System
The lectures for this course will be presented in an audio format using a webinar platform.
Enrollment is closed.
Presenter: Amanda Guth, DVM, PhD
Course Open: September 12-October 6, 2018
Real Time Sessions (RTS): Wednesdays, September 19 and 26, 2018; 9:30-11:30 pm ET (USA)
Course RTS Times in Your Area:
World Clock Converter
Level and Prerequisites:
This
intermediate course will be open to veterinarians
actively interested in the immune system and its role in preventing cancer.
VIN CE Course: Open to veterinarians.
This course is approved by RACE for veterinarians. (RACE 22-33945)
Course Information:
The immune system plays an important role in preventing cancer and attacking
malignant cells once a tumor occurs. This course is designed to explain the
interplay between tumor cells and the immune system during tumor development,
with an emphasis on the key immune cells that play roles in both eliminating
the tumor cells as well as assisting in tumor growth, as well as how the tumor
tricks the immune system in order to prevent antitumor immunity. Moreover, this
course will cover novel cancer immunotherapeutics, both currently available for
veterinary use and novel therapies being researched. After this course, participants
will have a better understanding of tumor immunity and available immune system-based
therapies to better inform their clients and consider alternate cancer therapies.
Week 1 (Real Time Session September 19, 2018):
Tumor Immunity
Presenter: Amanda Guth, DVM, PhD
Format: Audio
Objectives: Upon completion of this session, the participant should be able to
- understand the 3E's (elimination, equilibrium and escape) of
tumor development in an immune competent animal.
- learn about the key immune cells that play roles in tumor
elimination and tumor progression.
- know what cancer immunotherapies have been tested in veterinary
patients and which ones are currently available for use in small animals.
- know what new immunotherapies are being researched and might
appear in the veterinary market at some point.
Week 2 (Real Time Session September 26, 2018):
Immunotherapies
Presenter: Amanda Guth, DVM, PhD
Format: Audio
Objectives: Upon completion of this session, the participant should be able to
- understand the 3E's (elimination, equilibrium and escape)
of tumor development in an immune competent animal.
- learn about the key immune cells that play roles in tumor
elimination and tumor progression.
- know what cancer immunotherapies have been tested in veterinary
patients and which ones are currently available for use in small animals.
- know what new immunotherapies are being researched and might
appear in the veterinary market at some point.
Successful completion (scoring 80% or better) on the end-of-course test is required
to earn a certificate of completion for the course.
To learn more about the requirements for earning a CE certificate, please refer to
Receiving Your CE Credit and Course Completion Certificate.
Course Materials: Course materials will be available
in the course library prior to each Real Time Session.
Required Textbook(s): There is no required textbook for this course.
About the Presenter:
Amanda Guth received her PhD in 2003 from the University of Colorado
Health Sciences Center where she studied B cells and autoimmunity at National Jewish
Health in Denver, Colorado. She then completed her DVM at Colorado State University
in 2007 and worked as a post-doctoral fellow studying lung immunology and innate
immunity in cancer. She currently is a Research Scientist at Colorado State University
where she studies the role of myeloid cells in cancer and the development of novel
immunotherapies for cancer and metastatic disease. She also has an interest in
developing novel cancer vaccines and understanding the role of the immune system
in combination immunotherapy and chemotherapy or radiation therapy. She teaches
classes on tumor immunology, clinical trials and large animal immunology.
She co-wrote the Immunotherapy Chapter in
Withrow and MacEwen's Small Animal Clinical Oncology
5th edition textbook and the Cancer Immunotherapy chapter in
Kirk's Current Veterinary Therapy Volume XV.
Total CE Credit: 4
Tuition: Member $92 ($83 early bird special if enrolled by August 29, 2018)
Non-Member $169 ($152 early bird special if enrolled by August 29, 2018)
Prices are listed in US dollars.
*To ensure participants are ready and prepared for classes,
enrollment will close on September 19, 2018 at 5 pm ET (USA)
or when the maximum number of participants is reached.
*For more information on how online CE works, see the
Participant Resource Center.
To Enroll:
Enrollment is closed.
- Enrollment qualifications: VIN CE courses are open to
VIN member and non-member veterinarians. Veterinarians enrolling in a VSPN CE course
must be a VIN member. Veterinary support staff must be a VSPN member to enroll in a
VSPN CE or a VIN CE course open to VSPN member enrollment.
- Each enrollee must be able to receive emails from @vspn.org
and @vin.com addresses. Email is our major form of communication with participants;
personal emails are highly recommended rather than clinic/hospital email addresses.
- Each person is individually responsible for his/her own registration.
To ensure that all information received is secure and correct, please do not enroll
for a course on behalf of another individual.
- For further assistance call 800-846-0028 ext. 797 or email
CEonVIN@vin.com.
Please include the course title, your full name, and contact information in your correspondence.
"This program (22-33945) is approved by the AAVSB RACE to offer a
total of 4 CE Credits, with a maximum of 4 CE Credits being available to any individual
veterinarian.
This RACE approval is for the subject matter categories of:
Scientific,
using the delivery method of Interactive-Distance: (Web-based, Teleconference or Audio-Conference).
This approval is valid in jurisdictions which recognize AAVSB RACE; however, participants are
responsible for ascertaining each board's CE requirements."
Course withdrawal and refund policy: A complete refund of the paid course price will be
issued when your withdrawal request is received prior to the listed start date of the course.
If you wish to withdraw after the start date please contact the VIN office 800-846-0028 ext. 797
to discuss eligibility for a pro-rated refund.
*For more information on VIN's upcoming CE courses, check the
VIN Course Catalog.
Katherine James, DVM, PhD, DACVIM (SAIM)
VIN Education Director
VIN CE Services:
CEonVIN@vin.com
800-846-0028 or 530-756-4881; ext. 797
or direct line to VIN/VSPN from the United Kingdom: 01 45 222 6154
or direct line to VIN/VSPN from Australia: 02 6145 2357
800.700.4636 | CEonVIN@vin.com | 530.756.4881 | Fax: 530.756.6035
777 West Covell Blvd, Davis, CA 95616
Copyright 2002, Veterinary Information Network, Inc.
|
